Found 14 matching trials
A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder
PHASE3This is a study with an Open-Label (OL) phase followed by a randomized, Dou...
Location
Sage Investigational Site
A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder
PHASE3The primary purpose of this study is to evaluate the efficacy of SAGE-217 p...
Location
Sage Investigational Site
A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)
PHASE3This is a Phase 3, open-label, 1-year study of the safety, tolerability, an...
Location
Sage Investigational Site
A Study to Evaluate SAGE-217 in Participants With Severe Postpartum Depression
PHASE3The primary purpose of this study was to determine if treatment with SAGE-2...
Location
Sage Investigational Site
A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease
PHASE2This study assesses the safety, tolerability, pharmacokinetics and efficacy...
Location
Sage Investigational Site
A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Participants With Major Depressive Disorder
PHASE3This study is a phase 3, multicenter, double-blind, randomized, placebo-con...
Location
Sage Investigational Site
A Study to Assess the Pharmacodynamic Effects of SAGE-217 in Healthy Adults Using an Insomnia Model
PHASE1This study will assess the pharmacodynamic effects of SAGE-217 in approxima...
Location
Sage Investigational Site
A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)
PHASE3The purpose of this study to evaluate the efficacy of SAGE-217 in the treat...
Location
Sage Investigational Site
A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode
PHASE2This is an open-label study evaluating the safety, tolerability, pharmacoki...
Location
Sage Investigational Site
A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder
PHASE2This is a two-part (open-label followed by double-blind) study evaluating t...
Location
Sage Investigational Site